Page 1 of Clinical Trials for Chloroquine diphosphate, 104 Total Matches
- 1RecruitingLast Updated: March 23, 2012Condition(s): Carcinoma, Intraductal, Noninfiltrating; DCIS; Ductal Carcinoma In Situ
- 2CompletedLast Updated: April 20, 2009Condition(s): Malaria
- 3CompletedLast Updated: August 24, 2010Condition(s): Malaria Prophylaxis
- 4Not yet recruitingLast Updated: April 10, 2012Condition(s): Small Cell Lung Cancer
- 5RecruitingLast Updated: March 6, 2012Condition(s): Vivax Malaria
- 6Recruiting
- 7RecruitingLast Updated: April 2, 2012Condition(s): Small Cell Lung Cancer
- 8CompletedLast Updated: January 29, 2010Condition(s): Malaria Anaemia
- 9CompletedLast Updated: May 10, 2012Condition(s): Plasmodium Falciparum Malaria
- 10CompletedLast Updated: May 9, 2011Condition(s): PLASMODIUM FALCIPARUM MALARIA
- 11CompletedLast Updated: April 29, 2010Condition(s): Osteoarthritis of the Knee
- 12CompletedLast Updated: October 15, 2009Condition(s): Healthy Subjects; Healthy Volunteer
- 13TerminatedLast Updated: August 12, 2009Condition(s): HIV Infections
- 14CompletedLast Updated: February 21, 2012Condition(s): Metabolic Syndrome X; Overweight; Hypertension; Dyslipidemias; Prediabetic State
- 15TerminatedLast Updated: April 25, 2011Condition(s): Malaria, Falciparum
- 16RecruitingLast Updated: April 25, 2012Condition(s): Multiple Myeloma
- 17Active, not recruitingLast Updated: February 28, 2010Condition(s): Influenza
- 18TerminatedLast Updated: October 30, 2008Condition(s): Malaria, Falciparum
- 19Recruiting
- 20CompletedLast Updated: June 3, 2011Condition(s): Malaria, Falciparum
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Chloroquine+diphosphate
